![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 15, 11002-11009, April 14, 2000
§,
¶,
,
,

From the Departments of UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine
deacetylase (LpxC) catalyzes the second step in the biosynthesis of
lipid A, a unique amphiphilic molecule found in the outer membranes of
virtually all Gram-negative bacteria. Since lipid A biosynthesis is
required for bacterial growth, inhibitors of LpxC have potential utility as antibiotics. The enzymes of lipid A biosynthesis, including LpxC, are encoded by single copy genes in all sequenced Gram-negative genomes. We have now cloned, overexpressed, and purified LpxC from the
hyperthermophile Aquifex aeolicus. This heat-stable LpxC variant (the most divergent of all known LpxCs) displays 32% identity and 51% similarity over 277 amino acid residues out of the 305 in
Escherichia coli LpxC. Although A. aeolicus
LpxC deacetylates the substrate
UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine at a rate comparable with E. coli LpxC, a
phenyloxazoline-based hydroxamate that inhibits E. coli
LpxC with Ki of ~50 nM (Onishi,
H. R., Pelak, B. A., Gerckens, L. S., Silver, L. L., Kahan, F. M., Chen, M. H., Patchett, A. A.,
Galloway, S. M., Hyland, S. A., Anderson, M. S., and
Raetz, C. R. H. (1996) Science 274, 980-982)
does not inhibit A. aeolicus LpxC. To determine whether or
not broad-spectrum deacetylase inhibitors can be found, we have
designed a new class of hydroxamate-containing inhibitors of LpxC,
starting with the structure of the physiological substrate. Several of
these compounds inhibit both E. coli and A. aeolicus LpxC at similar concentrations. We have also identified
a phosphinate-containing substrate analog that inhibits both E. coli and A. aeolicus LpxC, suggesting that the LpxC
reaction proceeds by a mechanism similar to that described for other
zinc metalloamidases, like carboxypeptidase A and thermolysin. The
differences between the phenyloxazoline and the substrate-based LpxC
inhibitors might be exploited for developing novel antibiotics targeted
either against some or all Gram-negative strains. We suggest that LpxC
inhibitors with antibacterial activity be termed "deacetylins."
Biochemistry and
Chemistry, Duke University Medical Center, Durham, North
Carolina 27710 and the ** Department of Chemistry, University of
Alberta, Edmonton, Alberta, Canada T6G 2G2

To whom correspondence should be addressed. E-mail:
Raetz@biochem.duke.edu.
This article has been cited by other articles:
![]() |
I. Mochalkin, J. D. Knafels, and S. Lightle Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB-78485 inhibitor Protein Sci., March 1, 2008; 17(3): 450 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Barb, L. Jiang, C. R. H. Raetz, and P. Zhou Structure of the deacetylase LpxC bound to the antibiotic CHIR-090: Time-dependent inhibition and specificity in ligand binding PNAS, November 20, 2007; 104(47): 18433 - 18438. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zagorski Profile of Christian R. H. Raetz PNAS, October 30, 2007; 104(44): 17252 - 17254. [Full Text] [PDF] |
||||
![]() |
M. S. Trent, C. M. Stead, A. X. Tran, and J. V. Hankins Invited review: Diversity of endotoxin and its impact on pathogenesis Innate Immunity, August 1, 2006; 12(4): 205 - 223. [Abstract] [PDF] |
||||
![]() |
A. H. Williams, R. M. Immormino, D. T. Gewirth, and C. R. H. Raetz Structure of UDP-N-acetylglucosamine acyltransferase with a bound antibacterial pentadecapeptide PNAS, July 18, 2006; 103(29): 10877 - 10882. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Mdluli, P. R. Witte, T. Kline, A. W. Barb, A. L. Erwin, B. E. Mansfield, A. L. McClerren, M. C. Pirrung, L. N. Tumey, P. Warrener, et al. Molecular Validation of LpxC as an Antibacterial Drug Target in Pseudomonas aeruginosa. Antimicrob. Agents Chemother., June 1, 2006; 50(6): 2178 - 2184. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Blair, A. W. Schuttelkopf, J. I. MacRae, and D. M. F. van Aalten Structure and metal-dependent mechanism of peptidoglycan deacetylase, a streptococcal virulence factor PNAS, October 25, 2005; 102(43): 15429 - 15434. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hernick, H. A. Gennadios, D. A. Whittington, K. M. Rusche, D. W. Christianson, and C. A. Fierke UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine Deacetylase Functions through a General Acid-Base Catalyst Pair Mechanism J. Biol. Chem., April 29, 2005; 280(17): 16969 - 16978. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shulami, C. Furdui, N. Adir, Y. Shoham, K. S. Anderson, and T. Baasov A Reciprocal Single Mutation Affects the Metal Requirement of 3-Deoxy-D-manno-2-octulosonate-8-phosphate (KDO8P) Synthases from Aquifex pyrophilus and Escherichia coli J. Biol. Chem., October 22, 2004; 279(43): 45110 - 45120. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Whittington, K. M. Rusche, H. Shin, C. A. Fierke, and D. W. Christianson Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis PNAS, July 8, 2003; 100(14): 8146 - 8150. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Doerrler and C. R. H. Raetz ATPase Activity of the MsbA Lipid Flippase of Escherichia coli J. Biol. Chem., September 20, 2002; 277(39): 36697 - 36705. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Starner, W. E. Swords, M. A. Apicella, and P. B. McCray Jr. Susceptibility of Nontypeable Haemophilus influenzae to Human {beta}-Defensins Is Influenced by Lipooligosaccharide Acylation Infect. Immun., September 1, 2002; 70(9): 5287 - 5289. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Babinski, A. A. Ribeiro, and C. R. H. Raetz The Escherichia coli Gene Encoding the UDP-2,3-diacylglucosamine Pyrophosphatase of Lipid A Biosynthesis J. Biol. Chem., July 12, 2002; 277(29): 25937 - 25946. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Babinski, S. J. Kanjilal, and C. R. H. Raetz Accumulation of the Lipid A Precursor UDP-2,3-diacylglucosamine in an Escherichia coli Mutant Lacking the lpxH Gene J. Biol. Chem., July 12, 2002; 277(29): 25947 - 25956. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gronow and H. Brade Invited review: Lipopolysaccharide biosynthesis: which steps do bacteria need to survive? Innate Immunity, February 1, 2001; 7(1): 3 - 23. [Abstract] [PDF] |
||||
![]() |
N. R. Stanley, K. Findlay, B. C. Berks, and T. Palmer Escherichia coli Strains Blocked in Tat-Dependent Protein Export Exhibit Pleiotropic Defects in the Cell Envelope J. Bacteriol., January 1, 2001; 183(1): 139 - 144. [Abstract] [Full Text] |
||||
![]() |
C. R. Sweet, S. Lin, R. J. Cotter, and C. R. H. Raetz A Chlamydia trachomatis UDP-N-Acetylglucosamine Acyltransferase Selective for Myristoyl-Acyl Carrier Protein. EXPRESSION IN ESCHERICHIA COLI AND FORMATION OF HYBRID LIPID A SPECIES J. Biol. Chem., May 25, 2001; 276(22): 19565 - 19574. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |